219 related articles for article (PubMed ID: 28783374)
1. HIV and Cognitive Impairment in Clinical Practice: The Evaluation of a Stepwise Screening Protocol in Relation to Clinical Outcomes and Management.
Hakkers CS; Kraaijenhof JM; van Oers-Hazelzet EB; Visser-Meily AJMA; Hoepelman AIM; Arends JE; Barth RE
AIDS Patient Care STDS; 2017 Sep; 31(9):363-369. PubMed ID: 28783374
[TBL] [Abstract][Full Text] [Related]
2. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
[TBL] [Abstract][Full Text] [Related]
3. Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable?
Parry S; Zetler S; Kentridge A; Petrak J; Barber T
AIDS Care; 2017 Oct; 29(10):1275-1279. PubMed ID: 28292203
[TBL] [Abstract][Full Text] [Related]
4. Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients.
Janssen MA; Bosch M; Koopmans PP; Kessels RP
J Neurovirol; 2015 Aug; 21(4):383-90. PubMed ID: 25678141
[TBL] [Abstract][Full Text] [Related]
5. The Montreal Cognitive Assessment-Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa.
Hakkers CS; Beunders AJM; Ensing MHM; Barth RE; Boelema S; Devillé WLJ; Tempelman HA; Coutinho RA; Hoepelman AIM; Arends JE; van Zandvoort MJE
Int J Infect Dis; 2018 Feb; 67():36-40. PubMed ID: 29183843
[TBL] [Abstract][Full Text] [Related]
6. Functional deficits and other psychiatric associations with abnormal scores on the Montreal Cognitive Assessment (MoCA) in older HIV-infected patients.
Bourgeois JA; John M; Zepf R; Greene M; Frankel S; Hessol NA
Int Psychogeriatr; 2020 Jan; 32(1):105-118. PubMed ID: 31014404
[TBL] [Abstract][Full Text] [Related]
7. How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
Metral M; Nadin I; Locatelli I; Tarr PE; Calmy A; Kovari H; Brugger P; Cusini A; Gutbrod K; Schmid P; Schwind M; Kunze U; Di Benedetto C; Pignatti R; Du Pasquier R; Darling K; Cavassini M;
HIV Med; 2020 May; 21(5):342-348. PubMed ID: 31883203
[TBL] [Abstract][Full Text] [Related]
8. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
9. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV-2 population.
Almeida F; Macedo A; Trigo D; Abreu M; Guimarães M; Luís N; Pinho R; Tavares R
HIV Med; 2021 Mar; 22(3):212-217. PubMed ID: 33012065
[TBL] [Abstract][Full Text] [Related]
12. Screening for HIV-Associated Neurocognitive Impairment: Relevance of Psychological Factors and Era of Commencement of Antiretroviral Therapy.
Herrmann S; McKinnon E; Skinner M; Duracinsky M; Chaney R; Locke V; Mastaglia F
J Assoc Nurses AIDS Care; 2019; 30(1):42-50. PubMed ID: 30586348
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).
Milanini B; Ciccarelli N; Fabbiani M; Baldonero E; Limiti S; Gagliardini R; Borghetti A; D'Avino A; Mondi A; Colafigli M; Cauda R; Di Giambenedetto S
Clin Neuropsychol; 2016; 30(sup1):1457-1468. PubMed ID: 27180611
[TBL] [Abstract][Full Text] [Related]
14. The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders.
Costaggiu D; Pinna E; Serchisu L; Barcellona D; Piano P; Ortu F; Marongiu F; Mandas A
AIDS Care; 2021 Mar; 33(3):357-363. PubMed ID: 32183560
[TBL] [Abstract][Full Text] [Related]
15. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
[TBL] [Abstract][Full Text] [Related]
16. Impaired Neurocognitive Performance and Mortality in HIV: Assessing the Prognostic Value of the HIV-Dementia Scale.
Banerjee N; McIntosh RC; Ironson G
AIDS Behav; 2019 Dec; 23(12):3482-3492. PubMed ID: 30820848
[TBL] [Abstract][Full Text] [Related]
17. The Montreal Cognitive Assessment: A Pilot Study of a Brief Screening Tool for Mild and Moderate Cognitive Impairment in HIV-Positive Veterans.
Chartier M; Crouch PC; Tullis V; Catella S; Frawley E; Filanosky C; Carmody T; McQuaid J; Lampiris H; Wong JK
J Int Assoc Provid AIDS Care; 2015; 14(3):197-201. PubMed ID: 25487428
[TBL] [Abstract][Full Text] [Related]
18. HIV-related neurocognitive impairment screening: the patient's perspective on its utility and psychological impact.
Nightingale A; Ratcliffe D; Leonidou L; Margetts A; Asboe D; Gazzard B; Catalan J; Barber TJ
AIDS Care; 2014; 26(8):1036-41. PubMed ID: 24625218
[TBL] [Abstract][Full Text] [Related]
19. Montreal Cognitive Assessment Performance in HIV/AIDS: Impact of Systemic Factors.
Koenig N; Fujiwara E; Gill MJ; Power C
Can J Neurol Sci; 2016 Jan; 43(1):157-62. PubMed ID: 26635008
[TBL] [Abstract][Full Text] [Related]
20. Cognitive reserve and neuropsychological functioning in older HIV-infected people.
Milanini B; Ciccarelli N; Fabbiani M; Limiti S; Grima P; Rossetti B; Visconti E; Tamburrini E; Cauda R; Di Giambenedetto S
J Neurovirol; 2016 Oct; 22(5):575-583. PubMed ID: 26965299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
